With clinics planned throughout 2025, AYR Wellness provides communities with resources to rebuild their lives post-conviction.

Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down...

Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles.

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store c...

Analysts have a range of choices when valuing cannabis companies. Viridian commonly uses Discounted Cash Flow Analysis, Public ...

Roth MKM analyst Bill Kirk maintains Ayr Wellness (OTC:AYRWF) with a Buy and lowers the price target from $3.5 to $3.